SCHEMBL3852822

SCHEMBL3852822

CS(=O)(=O)c1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc5c(c4)OCO5)cc23)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 11/20 0.38
CYP1A2 P05177 10/20 0.38
CYP3A4 P08684 10/20 0.38
HSD17B10 Q99714 8/20 0.38
MAPK1 P28482 7/20 0.38
TSHR P16473 7/20 0.38
CYP2C9 P11712 6/20 0.38
USP2 O75604 4/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 3/20 0.38
CLK4 Q9HAZ1 16/20 0.37
CYP2C19 P33261 10/20 0.37
LMNA P02545 8/20 0.37
ALDH1A1 P00352 8/20 0.37
HIF1A Q16665 4/20 0.36
CLK1 P49759 8/20 0.35
DYRK1A Q13627 7/20 0.35
CLK2 P49760 6/20 0.35
CLK3 P49761 6/20 0.35
DYRK1B Q9Y463 6/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846261 0.87 CA12 (0.34) CYP2D6CYP1A2CYP3A4TSHRUSP2
SCHEMBL3849989 0.87 CYP2D6 (0.39) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3854489 0.86 PTGS2 (0.35) CYP2D6CYP1A2CYP3A4MAPK1TSHR
SCHEMBL3853047 0.86 CA12 (0.32) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3854275 0.86 CYP3A4 (0.33) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3855967 0.85 PIK3CD (0.41) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3847026 0.85 STK17B (0.32)
SCHEMBL3845263 0.85 CYP1A2 (0.34) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3851760 0.85 MAP4K4 (0.33) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3856580 0.85 MAPK1 (0.39) CYP2D6CYP1A2CYP3A4HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed